Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Webcast ImageWebcast
Q1 2019 Charles River Laboratories International, Inc. Earnings Conference Call (Replay)
05/07/19 at 8:30 a.m. ET

Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.


News Releases

DateTitle 
05/16/19Charles River Laboratories Invests in Resero Analytics™Printer Friendly Version
05/07/19Charles River Laboratories Announces First-Quarter 2019 ResultsPrinter Friendly Version
04/29/19Charles River Laboratories Completes the Acquisition of CitoxlabPrinter Friendly Version
04/11/19Charles River Laboratories Schedules First-Quarter 2019 Earnings Release and Conference CallPrinter Friendly Version
View More

Upcoming Events

There are currently no events scheduled.
View More

Stock Quote

CRL (common)
Price
$130.35
Change (%)
+ 1.62 (1.26%)
Volume
102,825
Exchange
NYSE
Data as of 05/21/19 2:59 p.m. ET
Data provided by Nasdaq.
Minimum 15 minutes delayed.

Refresh Quote

Investor Hotline

877-567-6CRL (6275)